Prognostic restaging after treatment initiation in patients with AL amyloidosis

The utility of systemic light chain (AL) amyloidosis staging systems has been validated for newly diagnosed patients, but their role in restaging after treatment has not been explored. We designed this study to evaluate whether the currently used systems are of prognostic value at 3 and 6 months of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Adv
Hlavní autoři: Abdallah, Nadine, Dispenzieri, Angela, Muchtar, Eli, Buadi, Francis K., Kapoor, Prashant, Lacy, Martha Q., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam A., Hayman, Suzanne R., Leung, Nelson, Dingli, David, Lust, John A., Go, Ronald S., Lin, Yi, Gonsalves, Wilson I., Kourelis, Taxiarchis, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A., Kumar, Shaji K.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2021
Témata:
Stimulus Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903228/
https://ncbi.nlm.nih.gov/pubmed/33595624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003782
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky